Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate 2Seventy Bio Inc before investing.

In this article, we go over a few key elements for understanding 2Seventy Bio Inc’s stock price such as:

• 2Seventy Bio Inc’s current stock price and volume
• Why 2Seventy Bio Inc’s stock price changed recently
• Upgrades and downgrades for TSVT from analysts
• TSVT’s stock price momentum as measured by its relative strength

About 2Seventy Bio Inc (TSVT)

Before we jump into 2Seventy Bio Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). Abecma is its B cell maturation antigen (BCMA)-targeted CAR T cell therapy for multiple myeloma, in collaboration with their partner Bristol Myers Squibb (BMS). ABECMA is a BCMA-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. Abecma uses a lentiviral vector (LVV), to deliver a chimeric antigen receptor (CAR), with the potential to program a patient’s own T cells to recognize the plasma cell specific BCMA, protein on the cell surface.

Want to learn more about 2Seventy Bio Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about 2Seventy Bio Inc.

2Seventy Bio Inc’s Stock Price as of Market Close

As of April 12, 2024, 4:00 PM, CST, 2Seventy Bio Inc’s stock price was $5.04.

2Seventy Bio Inc is down 8.7% from its previous closing price of $5.52.

During the last market session, 2Seventy Bio Inc’s stock traded between $5.11 and $5.52. Currently, there are 51.41 million shares of 2Seventy Bio Inc stock available for purchase.

Unfortunately, 2Seventy Bio Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

2Seventy Bio Inc Stock Price History

2Seventy Bio Inc’s (TSVT) price is currently down 5.79% so far this month.

During the month of April, 2Seventy Bio Inc’s stock price has reached a high of $5.99 and a low of $4.78.

Over the last year, 2Seventy Bio Inc has hit prices as high as $12.69 and as low as $1.54. Year to date, 2Seventy Bio Inc’s stock is down 46.21%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused 2Seventy Bio Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 11, 2024, there was 1 analyst who downgraded 2Seventy Bio Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate 2Seventy Bio Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on 2Seventy Bio Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

2Seventy Bio Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about 2Seventy Bio Inc (TSVT) by visiting AAII Stock Evaluator.

Relative Price Strength of 2Seventy Bio Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 11, 2024, 2Seventy Bio Inc has a weighted four-quarter relative price strength of -0.99%, which translates to a Momentum Score of 66 and is considered to be Strong.

Want to learn more about how 2Seventy Bio Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

2Seventy Bio Inc Stock Price: Bottom Line

As of April 12, 2024, 2Seventy Bio Inc’s stock price is $5.04, which is down 8.7% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like 2Seventy Bio Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.